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CalcineurinCyclosporine A (CsA), a widely used immunosuppressant shows cytotoxic effects by either inducing apoptosis or
redirecting the cell towards non-apoptotic cell death. However, there still remains a lacuna in understanding the
mechanism of CsA induced non-apoptotic cell death. In the present study we investigated calcineurin dependent
or independent cytotoxic effects of CsA, a calcineurin inhibitor, in cervical cancerous SiHa cells. Decreased cell
viability andmassive cytoplasmic vacuolationswere observed in CsA treated SiHa cells, having increased calcine-
urin activity. Endoplasmic reticulum (ER) stress and unfolded protein response (UPR), accompanied by a
decrease in cyclophilin B (ER resident PPIase), preceded the formation of the vacuoles. These vacuoles stained
positive for many ER resident markers conﬁrming their ER origin; but the absence of autophagosomal marker,
LC3II, ruled out autophagy. Extensively vacuolated cells eventually undergo cell death which lacked the typical
apoptotic features, but showed signiﬁcant decrease in AIP (ALG2 interacting protein) as seen in paraptosis. ER-
vacuolation was prevented by cycloheximide and salubrinal thereby indicating requirement of active protein
synthesis. Inhibiting calcineurin activity by either Tacrolimus (FK506) or by knockdown of calcineurin B subunit
did not result in either ER-stress or cellular vacuolation. However, knockdown of cyclophilin B by siRNA resulted
in increased expression of Bip and IRE1α, together with cytoplasmic vacuolation. In conclusion, we report that
persistent ER stress due to cyclophilin B inhibition in CsA treated cervical cancer cells caused cellular vacuolation
which culminated in a non-apoptotic cell death response similar to paraptosis. Additionally, the paraptotic effects
of CsA are independent of calcineurin inhibition.logy, Dept of Research, Institute
, Delhi 110070, India. Tel.: +91
trirama1@gmail.com,© 2014 Elsevier B.V. All rights reserved.1. Introduction
Cyclosporine A (CsA) is an undecapeptide isolated from the fungus
Tolypocladium inﬂatum and is a pharmacological inhibitor of calcineurin
activation [1]. Calcineurin being a serine/threonine protein phospha-
tase, (PPP3CA) dephosphorylates a number of targets such as NFAT
[2], GSK3ß [3], c-Jun [4], Bad [5], tau protein [6], cdk4 [7], and Drp1
[8]. Various cellular processes that depend on calcineurin signalling,
both in immune and in non-immune compartments, are affected on
inhibition by cyclosporine A.
Cyclosporine A binds to cyclophilins, the low molecular weight
proteins with peptidyl–prolyl cis–trans isomerase activity [9]. The
cyclosporine–cyclophilin complex inhibits calcineurin activity and blocksthe Ca2+-dependent signal transduction pathway of T-cell activation.
This immunosuppressant effect is exploited during organ transplants
making cyclosporine A, a widely used drug in allograft transplants.
Apart from its use in transplantation medicine, CsA is also used in auto-
immune disorders, psoriasis [10], atopic dermatitis [11], rheumatoid
arthritis, neurodegenerative disorders and cardiac hypertrophy [12].
The two major side effects of long term CsA treatment are nephro-
toxicity and skin cancers [13,14]. Nephrotoxicity results from renal cell
apoptosis. Apoptotic cell death mediated by CsA involves activation of
Fas/Fas-ligand, mitochondrial, endoplasmic reticulum (ER) and nitric
oxide-related signals leading to activation of caspases [15]. On the
contrary, CsA can also inhibit apoptosis by blocking mitochondrial
permeability transition pore (MPTP) and cytochrome c release [16–21].
Immunosuppressive treatment of CsA is often associatedwith cancer pro-
gression in a cell autonomousmanner [22,23]. CsA treatment, in contrast,
can also prevent growth of some cancer cells [24–26].
These contradictory reports prompted us to revaluate the calcineurin
dependent or independent effects of cyclosporine A on the growth of
cancer cervix cells. The cancer cervix cell line SiHa, showed increased cal-
cineurin activity compared to HaCaT, the non-tumorigenic counterpart.
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accompanied by massive cytoplasmic vacuolation with features of
non-apoptotic cell death similar to paraptosis. We now report that
cyclosporine A mediated paraptosis involves cyclophilin B inhibition
leading to persistent ER stress coupled with unfolded protein response
(UPR). In addition, salubrinal, an inhibitor of eIF2α dephosphorylation,
prevented CsA-induced changes. These ﬁndings have signiﬁcant implica-
tions in the understanding of lesser studied forms of non-apoptotic cell
death response caused by cyclosporine A and ER stress.
2. Materials and methods
2.1. Cell lines
SiHa, HeLa, HaCaT, U2OS, SaOs, A549 and HPLD cells were grown in
Dulbecco's modiﬁed Eagle's medium (HyClone, Thermo Scientiﬁc,
Logan, Utah, USA) supplemented with 2 U/ml penicillin and streptomy-
cin (Gibco BRL, Carlsbad, CA, USA), and 10% foetal bovine serum (Gibco
BRL, Carlsbad, CA, USA) under humiﬁed conditions at 37 °C and 5% CO2.
2.2. Antibodies and reagents
Antibodies against p21, BiP, CHOP, Calnexin, Phospho-AKT, PDI,
PERK, Phospho-SAPK/JNK, SAPK/JNK, caspase 3 and Phospho-eIF2α
were obtained from Cell Signalling Technology (Danvers, MA, USA).
Monoclonal anti α-tubulin and anti eIF2α antibodies were obtained
from Sigma-Aldrich (St. Louis, MO, USA). Anti PARP antibody was ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti
cyclophilin B and Anti ATF6 antibodieswere obtained fromAbcam (Cam-
bridge, UK). Lyso Tracker red, Mito Tracker and ER Tracker Blue White-
DPX for live-cell imaging and Alexa 488 conjugated secondary antibody
against rabbit IgG were obtained from Molecular Probes (Life Technolo-
gies, USA). HRP conjugated secondary antibodies against rabbit and
mouse IgG were obtained from Sigma-Aldrich (St. Louis, MO, USA) and
Bangalore Genei (Bangalore, India), respectively. DAPI was purchased
from Vector Laboratories, USA.
Cyclosporine A, MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide), wortmannin, UO126, SP 600125, cy-
cloheximide, camptothecin, Tacrolimus/FK506, Tween 20 andMalachite
green were obtained from Sigma-Aldrich (St. Louis, MO, USA). Speciﬁc
calcineurin substrate RII peptide, calmodulin, eIF-2α inhibitor
salubrinal, MG-132 and caspase inhibitor z-VAD FMK were obtained
from Calbiochem (San Diego, CA, USA). Cytotoxicity detection kit (LDH)
was obtained from Roche Diagnostics, (Mannheim, Germany). Live/
dead cytotoxicity assay kit was obtained from Molecular Probes, Life
Technologies, USA.
2.3. Cell viability assay
SiHa and HaCaT cells were seeded and grown for 24 h in 96 well
plates and treated with either vehicle or cyclosporine A for different
time intervals. To each well 100 μl (0.5 mg/ml) MTT reagent was
added and incubated at 37 °C for 3 h. Formazan precipitatewas extracted
by adding 100 μl DMSO and incubation at room temperature for 1 h.
Absorbance was recorded at 570 nm.
2.4. Lactate dehydrogenase (LDH) release as an assay for cell death
SiHa cells were grown in 96 well plates and treated with either
vehicle or cyclosporine A for different time intervals. Cell death at
different time intervals was determined by measuring the LDH activity
released from the dead cells using the cytotoxicity detection kit (Roche
Diagnostics, Mannheim, Germany). The assaywas performed according
to the manufacturer's protocol.2.5. Live/dead assay for viability and cytotoxicity
SiHa cells were grown in 35mmdish and treatedwith either vehicle
or cyclosporine A for 48 h. Cell viability and cytotoxicity were detected
based on the green (calcein) and red (EthD-1) ﬂuorescence from the
live and dead cells, respectively, followed by imaging the cells using
ﬂuorescence microscope. The assay was carried out using live/dead
viability/cytotoxicity kit (Molecular Probes, Life Technologies, USA)
according to the manufacturer's protocol.
2.6. Calcineurin phosphatase assay
Cells were washed thrice with Tris-buffered saline (100 mM Tris–
HCl, pH 7.5, 150 mM NaCl) and whole cell lysates were prepared in
cell lysis buffer (50 mM Tris–HCl, pH 7.5, 1 mM ascorbate, 1 mM DTT,
0.02% NP-40, 50 mg/l PMSF, 5 mg/l aprotinin and 5 mg/l pepstatin).
Lysis was carried out by three alternate freezing (in liquid N2) and
thawing (at 30 ° C) cycles followed by centrifugation at 13,000 rpm
for 10 min. Supernatants were collected and stored at −80 °C. Cell
lysates (20 μl) were mixed with 12.5 μl of (25:1) reaction buffer
(50 mM Tris, pH 7.5, 100 mM NaCl, 6 mM MgCl2, 0.5 mM DTT, 0.025%
NP-40, 0.5 mM CaCl2 and 5 mM ascorbic acid) and calmodulin
(25 μM) and preincubated at 30 °C for 10 min. Reaction was started
by adding 150 μM RII peptide (total reaction volume of 50 μl) and car-
ried out at 30 °C for 60min. Phosphate release was estimated by adding
200 μl of Malachite green reagent (4.2% ammonium molybdate, 0.045%
Malachite green and 0.2% Tween 20) followed by incubation at 30 °C for
30 min. Absorbance was measured at 655 nm using microplate reader
(Biorad, Hercules, CA, USA). Phosphatase activity was calculated as
μM Pi released/min/mg protein. Total protein was estimated using
Pierce BCA protein estimation kit (Thermo Scientiﬁc, Rockford, USA).
2.7. Preparation of cell homogenates and immunoblotting
For whole cell extract preparations, cells were collected in
microcentrifuge tubes (kept on ice) and washed thrice with 1X PBS
(0.8% NaCl, 0.02% KCl, 0.014% Na2HPO4, 0.024% KH2PO4), pH 7.4 and
lysed in RIPA lysis buffer (150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS and 50 mM Tris, pH 8.0) along with 1X protease
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Tubeswere
kept on rotor for 30 min followed by centrifugation at 13,000 rpm for
10 min and supernatants were collected. Total protein was estimated
using Pierce BCA protein estimation kit (Thermo Scientiﬁc, Rockford,
USA). Samples were boiled in 1X Laemmli buffer prior to loading on
polyacrylamide gels. Proteins were transferred to Hybond-P PVDFmem-
brane (GEHealthcare, Buckinghamshire, UK). Antibodieswere visualised
by ECL plus or prime chemiluminescence detection Kits (GE Healthcare,
Buckinghamshire, UK). Chemiluminescence signals were detected either
using the X-ray ﬁlms (GE Healthcare, Buckinghamshire, UK) or by
Fluorchem-E chemiluminescence detection system (Proteinsimple, CA,
USA).
2.8. DNA constructs and transfections
GFP-LC3 plasmid construct was obtained from Addgene (Addgene
plasmid 11546). The GFP-KDEL was constructed by cloning and
expressing the ER localization signal from TMED10/p24 protein at the
N-terminal and the ER retention signal, KDEL at the C-terminal of GFP
in pEGFPN1 mammalian expression vector. All the transfection experi-
ments were carried out using Lipofectamine 2000 transfection reagent
(Invitrogen, Carlsbad, CA, USA).
2.9. Knockdown of calcineurin α and cyclophilin B
The shRNA plasmids targeting various regions of calcineurin were
obtained from Sigma (St. Louis, MO, USA). Calcineurin knockdown
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subunit of human PPP3CA gene. The ﬁve shRNA sequences are as
follows: 5′CCGGTATCTTAAAGGCGCATCTTATCTCGAGATAAGATGCGCCT
TTAAGATATTTTTG3′,5′CCGGGCTGTATTTGTGGGCCTTGAACTCGAGTTC
AAGGCCCACAAATACAGCTTTTTG3′,5′CCGGGAAAGCTAATGCTAGTATAT
ACTCGAGTATATACTAGCATTAGCTTTCTTTTTG3′,5′CCGGCACCACAACATA
AGATCACTACTCGAGTAGTGATCTTATGTTGTGGTGTTTTT3′,5′CCGGGCTG
TATTTGTGGGCCTTGAACTCGAGTTCAAGGCCCACAAATACAGCTTTTT 3′.
The shRNA poolwas transfected in HEK-293 T cells alongwith retro-
viral packaging mix plasmids (Sigma-Aldrich,St. Louis, MO, USA) and
the cells were cultured for 60 h for complete packaging into retroviral
particles. The culturemedium containing the viral particleswas collected
and added to the HeLa cells for retroviral infection. The HeLa cells
were then cultured for another 48 h and knockdown was evaluated by
western blotting using antibody against PPP3CA. Non-target shRNA
(Sigma, St Lois, MO, USA) was used as control.
For knockdown of cyclophilin B, siRNA pool was purchased from
Dharmacon (ON_TARGET plus cyclophilin B control pool). HeLa cells
were transfected with human cyclophilin siRNA pool and cultured for
72 h after which knockdown was evaluated using western blotting.
The siGENOME non-targeting siRNA control pool was used as negative
control.2.10. Reverse transcription and PCR
Total RNAwas isolated fromcontrol (DMSO treated) and cyclosporine
A treated SiHa cells using Trizol reagent (Invitrogen, Carlsbad, CA,
USA) and reverse transcription was carried out by SuperScript III
RT (Invitrogen, Carlsbad, CA, USA) using oligo dT primer according
to the manufacturer's protocol. Human XBP1 (GenBank accession:
NM_005080.3) was ampliﬁed by PCR (forward primer: 5′ TTACGAGA
GAAAACTCATGGCC 3′ and reverse primer: 5′ GGGTCCAAGTTGTCCAGA
ATGC 3′).2.11. TUNEL assay
Apoptosis in SiHa cells post cyclosporine A and camptothecin treat-
ments were determined by Terminal deoxynucleotidyl transferase nick
end labelling (TUNEL) (Invitrogen, Carlsbad, CA, USA). The assay was
performed according to the manufacturer's protocol. The TUNEL posi-
tive cells were analysed by ﬂow Cytometry (FACS Aria, BD, CA, USA).2.12. Microscopy
Cells were grown on coverslips and ﬁxed in 4% paraformaldehyde
for immunoﬂuorescence studies. All ﬂuorescence and DIC images
were taken in Olympus IX 51 inverted microscope (Olympus, Tokyo,
Japan). All the confocal images were captured in LSM 510 Meta and
LSM 700 confocal laser scanning microscope (Zeiss, Germany). All
bright ﬁeld and phase contrast images were taken in Nikon TS 100
inverted microscope (Nikon, Tokyo, Japan).2.13. Electron microscopy
For electron microscopy the cells were initially ﬁxed in 2%
gluteraldehyde, washed in 0.1 M phosphate buffered saline followed by
secondary ﬁxation in 1% osmium tetroxide. Fixed cells were dehydrated
in grades of acetone and blocks were prepared in epoxy resin (EM
Sciences, PA, and USA). Ultrathin sections of 50–60 nm were mounted
on copper grids and counterstained with uranyl acetate and lead citrate.
The sections were viewed on high resolution Transmission Electron
Microscope, TECHNAI G2, FEI Company, Holland.3. Results
3.1. Increased calcineurin activity in cancer cervix cells, SiHa
Given the importance of calcineurin signalling in immune cells, we
wanted to evaluate the calcineurin activity in non-immune cells. For
this we made use of two different epithelial cell lines, viz, HaCaT an im-
mortalized keratinocytes and SiHa, a cervical cancer cell line. Both SiHa
and HeLa are tumorigenic and show a higher growth rate as compared
to the immortalized HaCaT cells (data not shown) and we asked the
question whether there is any difference in the calcineurin activity
between the non-cancerous cell and its counterpart cancerous cell
line. The calcineurin activity was evaluated using a calcineurin speciﬁc
substrate, phosphorylated RII peptide and the activity was found to
be higher in cancerous cells, SiHa (109.1 μM Pi/min/mg protein) and
HeLa (82.2 μM Pi/min/mg protein) compared to the non-cancerous
counterpart, HaCaT cells (48.9 μM Pi/min/mg protein) (Fig. 1A).3.2. Cyclosporine A treatment decreases cell survival
Cyclosporine A is a widely used inhibitor of calcineurin and since
cervical cancerous cells were found to have elevated calcineurin activity,
we next sought to determine how inhibition of this elevated calcineurin
activity affects growth of cells. Hence, in subsequent experiments SiHa
cells having high calcineurin activity were treated with varying doses
of cyclosporine A ranging from 1 to 20 μM. The calcineurin activity was
inhibited more than 60% at 10 μM dose of cyclosporine A when treated
for 24 h (Fig. 1B). SiHa cells were grown in continuous presence of 10
μM or 20 μM of CsA or vehicle for varying time durations (24 h–72 h)
and cell viability was evaluated by MTT assay which measures the mito-
chondrial activity and thus, metabolism of cells. The cell viability de-
creased in dose and time dependent manner. The cyclosporine A
treated cells showed in general a 57% and 66% reduction in viability as
compared to the control in 10 μM and 20 μM doses, respectively, post
48 h in MTT assay (Fig. 1C). Cellular growth was also checked by foci
formation and a 40% reduction in number of foci was observed in CsA
treated cells (Fig. 1 D and E). In the foci formation assay both the size
of colonies appeared small and numbers of colonies were low because
of growth inhibition and cell death, respectively, upon CsA treatment.
Therefore, to further estimate the growth arrest and cell death we
performed both cell cycle analysis and lactate dehydrogenase release
assay, respectively. CsA treated cells weremonitored for cell cycle distri-
bution by staining the ﬁxed cells with propidium iodide (PI) followed
by DNA content analysis using FACS (Fig. 1F). Decreased survival, as
observed in CsA treated SiHa cells is accompanied by following salient
features: (a) signiﬁcant arrest in G1 phase of cell cycle in the initial
time intervals (73.37% and 82.78% in control vs. CsA treated cells, respec-
tively, at 24 h), (b) very few cells in the S phase (19.56% and 3.41% in con-
trol vs. CsA treated cells, respectively, at 24 h) and (c) at later time
intervals (48 h and 72 h) the appearance of a sub-G0 peakwhich is indic-
ative of cell death. The growth arrest in CsA treated cells is accompanied
by increased level of cell cycle inhibitors (CDKI's) viz., p21 (Cip1) amark-
er of growth arrest (Fig. 1G). Togetherwith growth arrest, CsA treatment
also resulted in cell death which increased in time dependent manner
and this is supported by release of lactate dehydrogenase (LDH). LDH
assay being a directmeasurement of cell deathmeasures the LDH release
as a result of loss of membrane permeability, a feature of dead cells. We
found cell death to increase at later time points from almost 40% at 72 h
to 70% at 96 h in SiHa cells treated with 20 μMCsA. (Fig. 1H). The differ-
ences obtained in MTT assay and LDH release assay can be attributed to
the fact that CsA treatment also leads to vacuolation ofmitochondria and
thus interferes with the mitochondrial activity. This might result in met-
abolically impaired, yet viable cell as membrane permeability is not lost.
The nature of cell death appears to be non-apoptotic in nature and this is
described in details in the Section 3.10.
Fig. 1. Effects of cyclosporine A on growth of SiHa cells: (A) Calcineurin phosphatase activity in SiHa, HeLa and HaCaT cells. The calcineurin activity was signiﬁcantly higher (⁎P b 0.05
Student's Unpaired t-test) in cancer cervix cell line, SiHa as compared to the immortalized counterpart, HaCaT cells. Activity values are given as μM Pi/min/mg protein. (B) Calcineurin
activity in SiHa cells treated with different concentrations of CsA (1 μM, 5 μM and 10 μM) for 24 h. The activity of calcineurin is represented as percent control (μM Pi/min/mg protein).
Calcineurin activity was measured in the cell homogenates using the phosphorylated RII peptide and phosphate release was measured by malachite green reagent. The bars represent
mean± s.e.m. from three independent experiments (⁎P b 0.05, ⁎⁎P b 0.01 Student's Unpaired t-test). (C) Cell viability, asmeasured by A570 nm of formazan formed inMTT assay, revealed
decline in viability of cells treatedwith CsA (10 μM, 20 μM) in a dose and time dependentmanner. The bars representmean± s.e.m. from three independent experiments. The values have
been represented as percentage of control for the indicated time points (D, E). Foci formation assaywas performed on SiHa cells treatedwith CsA (10 μM)or vehicle (control). 5 × 103 cells
were plated in the presence or absence of CsA and changed to freshmedium on the 3rd day. Cells were then ﬁxed and stained with 0.1% crystal violet on the 10th day and the numbers of
fociwere counted. (F) Distribution of cells in various phases of cell cycle represented as percentage of cells in each cycling phase in control (−) and 10 μMCsA (+) treated cells. Cells were
harvested at various time intervals, ﬁxed in 70% ethanol, stainedwith propidium iodide and analysed by FACS. Note, for cell cycle assay we pooled both the adhered cells and the ﬂoaters.
(G) Increased expression of cyclin dependent kinase inhibitor, p21, in CsA (10 μM) treated cells (+) as compared to control (−) at different time intervals. Tubulin served as a loading
control. (H) Cell death was assessed by lactate dehydrogenase (LDH) release in cyclosporine A (20 μM) treated cells (⁎⁎P b 0.01, ⁎⁎⁎P b 0.001 Student's Unpaired t-test).
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A striking feature of CsA-treated SiHa cells was occurrence of mas-
sive cytoplasmic vacuolation (Fig. 2A, B). Typically, the vacuoles appear
very small at 12 h and bigger vacuoles start to appear by 24 h both in the
perinuclear region and the entire cytoplasm (Supplementary S1). The
vacuole numbers and size increase with progression of time
(48–72 h). Interestingly, the vacuolated cells show an intact nucleus
which at times is pushed towards the periphery as the vacuoles tend
to grow in size. The vacuoles persisted even after removal of CsA and
continued to increase in number as well as in size, indicative of a non-
reversible process. Live cell imaging of the treated cells showed that
the vacuolated cells, at later time points undergo cell death and ﬂoataway (Supplementary Fig. S2A). This was also evident from the live/
dead cell assay. The live cells take up non-ﬂuorescent calcein stain and
convert it to a ﬂuorescent form due to their intracellular esterase
activity and appear green; while the dead cells appear red as they
take up red-ﬂuorescent ethidium homodimer-1 because of loss of
membrane permeability (Supplementary Fig. S2B). These results are
further elaborated in later section describing the nature of cell death.
Cytoplasmic vacuolation, albeit to a different degrees, was observed
when different cell types such as HaCaT (keratinocytes), HeLa and
SiHa (cervical cancer), HPLD (lung epithelium), A549 (lung carcinoma),
U2OS and Saos-2 (osteosarcoma), were treated with CsA (20 μM)
(Fig. 2C). The vacuolation due to cyclosporine A treatment therefore
appears to be a general feature of other mammalian cell types also.
Fig. 2.Cyclosporine treatment inducesmassive cytoplasmic vacuolation. (A) CsA induces cytoplasmic vacuolation in a time dependentmanner. SiHa cellswere treatedwith different doses
of CsA (5 μM,10 μMand 20 μM) for indicated time points. At least 300 cellswere counted at different time intervals and percentage vacuolated cellswere calculated and data represented is
mean ± s.e.m. from three independent experiments. (B) CsA (20 μM) treated cells showed perinuclear vacuolation (arrow) at 24 h and massive vacuolation in cytoplasm at 48 h.
(C) Cyclosporine A induces cytoplasmic vacuolation in cell types of various origins such as HeLa (cervical cell carcinoma), A549 (lung adenocarcinoma), U2OS (osteosarcoma), HaCaT
(immortalized keratinocytes), HPLD (immortalized type II lung epithelium) and Saos-2 (osteosarcoma). Cells were treated with 20 μM CsA for 48 h before imaging. All the images
were taken at 40× magniﬁcation using phase contrast microscope.
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not prevent the vacuole formation, indicating a non-reversible effect of
cyclosporine A treatment.
Vacuolation induced by CsA was a prominent feature of the cervical
cancer cell lines, SiHa and HeLa cells. Hence, for all the subsequent
experiments evaluating the nature of cellular vacuoles and mode of
growth inhibition following cyclosporine A treatment were performed
using these two cell lines as they also showed elevated calcineurin
activity.3.4. Non-acidic and non-autophagic nature of the CsA-induced vacuoles in
SiHa cells
The nature and origin of the vacuoles was next evaluated. Since, the
vacuoles appear at the perinuclear region we suspected the involve-
ment ofmembrane network system viz., lysosomes or/and endoplasmic
reticulum (ER) as the source of these vacuoles. The lysosomal compart-
ment is involved in the process of autophagywhich is also accompanied
by cellular vacuolation. To evaluate if the vacuoles are autophagosomes,
Fig. 3. Nature of cytoplasmic vacuoles in CsA-treated cells. (A) Detection of autophagymarker, LC3. The HeLa cells were transfected with LC3-GFP plasmid and its expression pattern was
noted by confocal microscope. Note the punctate LC3 staining pattern in rapamycin treated cells indicative of autophagy and its absence in vacuoles (indicated by arrow) of CsA (20 μM)
treated HeLa cells. (B) Immunoblot analysis showing expression levels of LC3-I and lipidated LC3-II protein in SiHa cells treated with CsA (10 μM) for indicated time points. Rapamycin
(Rapa) treated cells were used as a positive control. Tubulin served as a loading control. (C) Acridine orange staining in control and CsA (20 μM, 48 h) treated SiHa cells. Cells were stained
with acridine orange (0.01%) for 5 min and were imaged using ﬂuorescence microscope. Orange and green ﬂuorescence is indicative of the lysosomal compartment and nucleic acid, re-
spectively. Note that the vacuoles do not show any ﬂuorescence. Images for acridine orange staining were taken at 40× magniﬁcation.
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associated light chain protein (MAP1-LC3), was examined by transfec-
tion of the cells with GFP-LC3 plasmid (Addgene, USA) followed by
CsA treatment. As a positive control, cells were treated with rapamycin
(1 μM, 72 h), a strong inducer of autophagy. A punctate staining for GFP-
LC3 was noted in the rapamycin treated autophagic cells. In contrast,
majority of the CsA treated cells showed diffused pattern of GFP-LC3
which did not localize either inside the vacuoles or on the vacuolar
membrane thereby reafﬁrming that these vacuoles are not
autophagosomes by nature (Fig. 3A). In addition, the expression levels
of LC3-I and the lipidated LC3-II were also evaluated by immunoblot
assay. The levels of LC3-II remain unaffected in CsA treated cells as com-
pared to control (Fig. 3B). The signal ratio between LC3-I and LC3-II
remained unaffected in CsA treated cells. These results indicated the ab-
sence of autophagic vacuoles following CsA treatment. To test if CsAinduced vacuoles are acidic in nature, a popularly used vital staining
dye viz., and acridine orange was used. Acridine orange emits an orange
ﬂuorescence in the acidic medium and emits green ﬂuorescence in the
presence of DNA/RNA [27,28]. In the control cells the acidic compartment
(orange ﬂuorescence) was mainly localized to the peri-nuclear compart-
ment (Fig. 3C). The CsA treated cells showed neither an increase in the
orange ﬂuorescence nor its localization inside the vacuoles.
Thus, the acridine orange staining of CsA treated cells indicated a
non-acidic nature of the vacuoles. Since lysosomes are also acidic in
nature we ruled out the involvement of lysosomal compartment in
vacuole formation by CsA. Additionally, Lyso Tracker red staining was
also performed on the CsA treated HeLa cells. The Lyso Tracker stain
has high selectivity for acidic organelles. The Lyso Tracker showed a
peri-nuclear punctate staining in both control and CsA treated cells.
Further, in the CsA treated cells the punctate lysosomal structures
2503B.M. Ram, G. Ramakrishna / Biochimica et Biophysica Acta 1843 (2014) 2497–2512were not co-localized with the vacuoles (Fig. 4A). The above observa-
tions provide strong evidence for the non-acidic and non-autophagic
nature of the vacuoles in CsA-treated cells.
3.5. Cyclosporine A treatment results in endoplasmic reticulum dilation
In the previous experiment the Lyso Tracker was used in combina-
tion with the endoplasmic reticulum (ER)-Tracker blue white DPX
stain which stains speciﬁcally the ER membranes. As expected the con-
trol cells showed a reticular pattern for endoplasmic reticulum (Fig. 4A).
However, the vacuolar membrane in the CsA treated cells appeared
positive for ER-Tracker suggesting that ERmembranes rather than lyso-
somes as the source of the vacuoles. Next, we used Calnexin a type-I
integral membrane protein which is localized to the endoplasmic
reticulum [29,30]. As is evident in Fig. 4B, the vacuolar rims of the CsA
treated cells showed green staining for calnexin suggestive of an ER-
origin of the vacuoles. To rule out the involvement of mitochondria,
we used Mito Tracker red stain which did not co-localize with either
the vacuolar lumen or its membrane in CsA treated cells (Fig. 4C).
These experiments clearly suggested non-involvement of either
lysosome ormitochondria in the process of cellular vacuolation; however
they also pointed towards a role of ER in the origin of the vacuoles. An
additional conﬁrmation of ER was therefore done by transfecting the
HeLa cells with an ER-reporter GFP construct viz., KDEL-GFP which
contains the ER retention signal and hence speciﬁcally localized to the
ER lumen. CsA treated HeLa cells transiently transfected with KDEL-GFP
showed its localization inside the vacuoles thereby further conﬁrming
dilation of ER-lumen (Fig. 4C). To further conﬁrm the ER-origin of the
vacuoles we performed electron microscopy. The electron micrographs
of CsA treated cells showed dilated endoplasmic reticulum (ER) which
also contained electron densematerial, while the nucleus appeared intact
(Supplementary Fig. S3A). The vacuoles appeared to be dilations of ER
cisternae and additionally, perinuclear space dilation was also visible
following CsA treatment. The foregoing results indicated that CsA
induced disruption of the endoplasmic reticulum architecture leading to
its dilation and extensive vacuolation.
3.6. Cyclosporine A causes endoplasmic reticulum stress and mounts
unfolded protein response
In view of dilation of ER-lumen, we reasoned that CsA induced
vacuolizationmay be preceded by induction of ER-stress.We performed
a time course experiment to study ER-stress and activation of unfolded
protein response (UPR) by evaluating expression of certain ER resident
proteins involved in protein folding. Immunoblot analysis of the cells as
early as 12 h of treatment with CsA demonstrated increased expression
of glucose-regulated protein BiP/GRP78, a hallmark of UPR activation
along with C/EBP-homologous protein CHOP, reaching the peak by
24–36 h when the vacuoles start to appear (Fig. 5A). The increased
expression of endoribonuclease, inositol requiring enzyme 1 (IRE1α),
was also accompanied by mRNA splicing of X-box binding protein
(XBP1) which continued beyond 36 h indicative of persistent ER-stress
(Fig. 5A). Additionally, an increase in expression of PKR like ER
kinase (PERK) and phosphorylation status of eukaryotic initiation factor
(eIF2α) was also observed, reiterating activation of UPR in CsA-treated
cells. However, there was no change in total eIF2α levels and ATF 6
levels or its activation (Fig. 5A). Interestingly, the levels of PDI also
remained unaffected following CsA treatment.
3.7. CsA induced vacuolation was reversed by treatment with
cycloheximide and salubrinal
Overload of protein in the ER-lumen could lead to its dilation,
thus we argued that abrogating synthesis of protein could help
in cell survival. Indeed halting of protein synthesis by addition of
cycloheximide (24 h) prevented the CsA induced cytoplasmicvacuolation (Fig. 5B, C). This indicated an active role of ER protein load
in vacuolation process. Activation of PERK pathway leading to eIF2α
phosphorylation is another way of halting of protein synthesis machin-
ery. Salubrinal, a protein phosphatase 1 (PP1) inhibitor, is known to pre-
vent dephosphorylation of eIF2α and also ER stress related cell death
[31]. We therefore evaluated the effect of salubrinal in CsA-treated
cells and found that vacuolation is signiﬁcantly reduced (Fig. 5D, E)
along with a robust increase in levels of eIF2α phosphorylation
(Fig. 5F). Treatment with CsA or salubrinal alone for 24 and 48 h in-
creased eIF2α phosphorylation (Fig. 5F). Intriguingly, salubrinal in the
presence of CsA also caused enhanced expression of ER stress related
genes viz., CHOP (Fig. 5G, Figure Supplementary S3B) and BiP (Fig. 5G,
H and Figure Supplementary S3B). These observationsmaybe attributed
to the fact that ER stress genes are upregulated in the presence of
salubrinal as a preventive measure to relieve the cells from ER stress
thereby maintaining the ER homeostasis to ensure proper protein fold-
ing. On the other hand salubrinal also prevented the activation of p-JNK
induced by CsA at 72 h (Supplementary S3B). These results support that
salubrinal acts to counteract the CsA induced ER-stress towards a
survival strategy preventing the induction of cellular vacuoles.
3.8. Cytoplasmic vacuolation is independent of calcineurin inhibition
Another calcineurin inhibitor, FK-506, inhibits calcineurin activity by
more than 50% at 10 μM concentration, which was comparable to the
inhibition following CsA treatment (Fig. 6A). Therefore, we asked the
question if FK-506 can also induce ER stress and cytoplasmic vacuola-
tion in SiHa cells similar to CsA. Interestingly, we did not ﬁnd any
change in the levels of BiP and IRE1α following treatment with FK-
506 (10 μM for 24 h and 48 h) indicating the absence of ER stress
(Fig. 6B). Also the cytoplasmic vacuoles were not seen in the SiHa cells
when treated with 20 μMof FK-506 for 48 h (Fig. 6C). The above results
with FK-506 treatment clearly indicated that ER-stress response is inde-
pendent of calcineurin inhibition. To conﬁrm this further, calcineurin α
speciﬁc shRNA targeting was done for knocking it down in HeLa cells.
The expression levels of BiP and PDI remained same in both non-target
control cells and calcineurin knockdown cells (Fig. 6D). Further cellular
vacuolation was not seen in calcineurin knockdown cells (Fig. 6E).
These results conﬁrmed that calcineurin inhibition is not involved in
ER stress induced vacuolation process. Both FK-506 and CsA bind to dif-
ferent binding partners, FKBP and cyclophilins, respectively, to inhibit
calcineurin activity. Thus, the occurrence of cytoplasmic vacuolation ap-
pears to be uniquely associated with only CsA treatment and not with
FK-506. Hence, we surmise a calcineurin independent and cyclophilin
dependent effect of CsA in cytoplasmic vacuolation. Furthermore, we
used ER stressors such as thapsigargin (TG) and tunicamycin (TM) to
checkwhether these too can induce cytoplasmic vacuolation. As expect-
ed, BiP levels were increased 24 h and 48 h post treatmentwith 2 μMTG
and 1 μg/ml TM (Fig. 6F). Interestingly, tunicamycin treatment showed
cellular vacuolation similar to CsA in SiHa cells post 24 h treatment
while very few vacuoles were found in thapsigargin treated cells
(Fig. 6G). This in turn indicated that ER stress is prerequisite for cellular
vacuole formation; nevertheless ER stress does not always lead to
vacuolation. Brieﬂy, it is the degree and nature of ER-stresswhich deter-
mines the vacuole formation.
3.9. Cyclophilin B expression in CsA treated cells and siRNA of cyclophilin B
CsAworks by interacting through its binding partner cyclophilins. In
fact, it has been earlier shown that CsA can regulate the expression
levels of cyclophilin A [32]. As CsA treatment induced ER-dilation, we
tried evaluating the levels of cyclophilin B, an ER resident protein, in
the CsA treated cells. A signiﬁcant decrease in levels of cyclophilin B
was observed in SiHa cells following exposure to CsA (Fig. 7A, B). We
further checked whether decrease in cyclophilin B levels were due to
inhibition of its synthesis or its degradation. SiHa cells were treated
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or proteasomal inhibitor, MG-132. Cyclophilin B levels were restored
in case of proteasomal inhibition while it decreased more in presenceof cycloheximide. This suggested that cyclophilin B levels decrease
upon CsA treatment due to its proteasomal degradation (Fig. 7C, D).
Since cyclophilin B is a resident of ER and has a higher afﬁnity for CsA
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knockdown will lead to cellular vacuolation and ER stress response.
Hence, short interfering RNA targeting sequence, speciﬁc for cyclophilin
Bwas transfected into HeLa cells. An effective knockdown of cyclophilin
B by N80% was noted, which in turn was accompanied by increased ex-
pression of UPR markers, Bip and IRE1αwith no change in eIF2α levels
(Fig. 7E). We also found activation of JNK in CypB knockdown cells.
Cyclophilin B knockdownwas accompanied by cytoplasmic vacuolation
in HeLa cells also (Fig. 7F, G).
3.10. Cyclosporine A mediated ER stress leads to a non-apoptotic cell
death response
Massive vacuolation occurred between 48 and 72 h of treatment
with CsA. These vacuolated cells appeared dead as they usually ﬂoat
away (Fig. 8A) as has been described in an earlier Section (3.2). The ab-
sence of necrosis in the vacuolated cells attached to the substratumwas
indicated by lack of staining with propidium iodide, but the cells that
lifted up from the substratum stained positive indicating cellular degen-
eration and death (Fig. 8A).We next evaluated the presence of hallmark
features of apoptosis in the CsA-treated SiHa cells, by comparing with
oleandrin and camptothecin treated apoptotic cells. The twin features
such as lack of nuclear fragmentation on DAPI staining and absence of
PARP and caspase 3 cleavages in these cells ruled out apoptosis
(Fig. 8B, C andD). TUNEL stainingwas also used as an additional marker
to evaluate DNA damage and apoptosis (Fig. 8E). The untreated cells
showed intrinsic apoptosis (16% TUNEL positivity) which was sensitive
to z-VAD-FMK, a pan-caspase inhibitor. After correcting for the back-
ground intrinsic apoptosis only minimal apoptosis (24.4%–16% = 8.4%
TUNEL positivity) was observed in CsA-treated cells which in turn gets
partly blocked on addition of z-VAD. Therefore, we surmise that in gen-
eral z-VADonly partly inhibits the intrinsic apoptosis in CsA treated cells
(as 7.3% TUNEL positive cellswere still present) and further it did not re-
verse the vacuolation in the treated cells. In contrast the camptothecin-
treated cells showed robust apoptosis (77.6%) which could be partially
reversed by addition of z-VAD-FMK (57.8%).
3.11. Cyclosporine A induced vacuolation and cell death resembles
paraptosis
From the foregoing studies, the features of cell death in CsA-treated
cells differed from necrosis and apoptosis but the distinctive ER vacuo-
lation is common with the alternate form of cell death viz., paraptosis
[34]. Paraptosis is characterized by activation of the IGFR1 and MAPK
signalling [35]. We therefore checked for activation of certain signalling
pathways such as Ras and PI3 kinase. In CsA treated cells a higher level
of Ras-GTPwas not accompanied by activation of its downstream target
Raf (Fig. 9A, B). We also noted a signiﬁcant increase in p-AKT levels fol-
lowing the CsA treatment suggesting activation of PI3K pathway
(Fig. 9C, D). AIP, an ALG2 interacting protein is a known inhibitor of
paraptosis thereby indicating that low levels of AIP is associated with
the phenomenon of paraptosis. Accordingly, we observed downregula-
tion of AIP expression in CsA treated cells (Fig. 9C, E). JNK signalling is
yet another feature associated with paraptosis. Activation of JNK was
observed at 48 h and it appeared more prominent at 60 h interval fol-
lowing CsA treatment (Fig. 9G). Treatment with JNK inhibitor,
SP600125 partially prevented the loss of viability by CsA (Fig. 9F).
While SP600125 was able to prevent activation of JNK, intriguingly the
downregulation of AIP1 was not prevented (Fig. 9H). JNK activation atFig. 4. Cytoplasmic vacuoles in CsA treated cells are derived from endoplasmic reticulum. (A)
(blue). HeLa cells were either left untreated (control) or treated with CsA (20 μM) for 24 h pri
is indicated as N. (B) Confocal microscopy images of HeLa cells stained with ER-membrane bo
4% formaldehyde and staining with calnexin (green). Nuclei were counterstained with DAPI (
vacuoles (V) colocalizewith ER reporter, GFP-KDEL. HeLa cells were transfectedwith GFP fused
with CsA (20 μM) for 24 h before imaging. Simultaneously cells were also stained with Mito Tra
while mitochondria (red) is not detected in the vacuoles or on the vacuolar membrane. Nucleulater time intervals (60 h) might occur due to activation of IRE1α cas-
cade as JNK is a downstream target of the latter. These results indicate
resemblance to paraptosis following the CsA treatment. Activation of
AKT at early time points and inhibition of vacuolation by PI3K inhibitor
wortmannin suggested the role of PI3K pathway in CsA induced cellular
vacuolation (Fig. 9I, J). MEK inhibitor, U0126, which can prevent
paraptosis was unable to inhibit CsA induced vacuolation in SiHa cells
(Fig. 9I, J).
4. Discussion
The two well known actions of CsA are inhibition of the calcineurin-
NFAT signalling and of mitochondrial permeability pore transition.
Additionally, its role in ER stress is now recognized [36–39]. The present
study using SiHa, cervical cancer cells with high calcineurin activity
ascribes the role of CsA in persistent ER stress and unfolded protein
response. We also describe an unusual form of caspase-independent
paraptotic type of cell death as an additional mechanism for cellular
toxicity of CsA.
4.1. CsA, ER stress and role of cyclophilins
The endoplasmic reticulum provides a specialized niche for protein
maturation which includes posttranslational modiﬁcation, proper fold-
ing, attainment of native state and ﬁnally their transport. We present
three lines of evidence that cyclosporine A is involved in ER-stress and
consequent UPR response: (a) activation of IRE1 and the persistent
XBP1 cleavage constitutes the transcription dependent pathway which
lead to transcriptional activation of ER chaperone such as BiP and ER
stress regulated protein, CHOP, (b) global translation inhibition by the
elevated eIF2α phosphorylation levels, and (c) the prevention of cyto-
plasmic vacuolation by either addition of cycloheximide or salubrinal
which can cause global shut down of protein translation machinery
thereby preventing accumulation of misfolded protein. Inhibiting
calcineurin either by Tacrolimus/FK-506 or by knocking down of
cyclophilin B by shRNA revealed that cytoplasmic vacuoles are formed
independent of calcineurin inhibition. Though both CsA and FK-506 in-
hibit calcineurin, their modes of action differ as they bind to different
binding partners viz., cyclophilins and FKBP12, respectively. Collectively
the differential effects of CsA and FK-506 on cytoplasmic vacuolation
indicates a cyclophilin mediated and calcineurin independent effect of
the former. This indicates the importance of cyclophilins in regulating
cellular processes on their ownwithout the involvement of calcineurin.
This is further supported by other studies where cyclosporine A was
found to inhibit mitochondrial membrane potential and angiogenesis
in a calcineurin independent manner [40,41].
Cyclosporine A binds to cyclophilins and inhibits their PPIase activity
which is needed for proper folding of the proteins in the ER [42,43].
Inhibition of cyclophilin B has a pivotal role in suppression of IgG bio-
synthesis [44], whereas its absence makes cells more sensitive to ER
stress leading to cell death by apoptosis [42,45]. Agents causing ER
stress upregulate cyclophilin B expression [45]. However, we observed
that CsA-treated cells show a signiﬁcant decline in levels of cyclophilin
B and this is accompanied by persistent ER stress. CsA can bind to all
the 20 different cyclophilins with varied afﬁnities. Mitochondrial per-
meability transition pore is inhibited on binding of CsA to cyclophilin
D [16,21] and this in turn lowers the energy status of the cell. Knock-
down of cytoplasmic cyclophilin A can lead to ER stress [36]. An
increased expression of cyclophilin B is noted consequent to ER stressConfocal microscopy images of HeLa cells stained with Lyso Tracker (red) and ER Tracker
or to staining. The vacuoles (V) are indicated by arrows in the CsA treated panel. Nucleus
und marker, calnexin. Cells were treated with 20 μM CsA for 24 h, followed by ﬁxation in
blue). Vacuoles in CsA treated panel is indicated by arrows. (C) CsA induced cytoplasmic
to the ER retention signal sequence, KDEL. After 24 h of transfection, the cells were treated
cker (red). Note localization of GFP-KDEL inside the vacuoles (arrow) in CsA treated cells,
s is indicated as N.
Fig. 5. Endoplasmic reticulum-stress mediated unfolded protein response in CsA treated SiHa cells and prevention of vacuolation by cycloheximide and salubrinal. (A) Immunoblotting
analysis revealed increased expression of ER stress pathways viz., PERK, eIF2α and IRE1 together with higher levels of ER chaperons such as BiP, in addition to transcription factor
CHOP and the splicing of XBP1 in CsA treated cells. No change was found in PDI and ATF6 expression upon CsA treatment. Tubulin was used as a loading control for protein gels while
GAPDH served as a RNA loading control. One representative blot is shown from three independent experiments. SiHa cells were treated with CsA (10 μM) for indicated time points
prior to preparation of lysates. (B, C) Cytoplasmic vacuolation was inhibited following the addition of cycloheximide (ChX). SiHa cells were treated with either CsA (20 μM) alone or
along with cycloheximide (5 μg/ml) for 48 h and percentage vacuolated cells were calculated by counting at least 300 cells in three independent experiments. Images were taken
using 20× objective. (D, E) Abrogation of CsA (20 μM for 72 h) induced cytoplasmic vacuolation by salubrinal treatment (75 μM for 72 h). Quantiﬁcation of the percentage of vacuolated
cells was done by counting at least 300 cells each from three different experiments. The bars representmean± s.e.m. from three independent experiments (⁎⁎P b 0.01 Student's Unpaired
t-test). Imageswere taken using 20× objective. (F) Effect of salubrinal on UPR. Cells were treatedwith CsA (10 μM) in the presence (+) or absence (−) of 75 μMof salubrinal (Sal) for 24
and 48 h, which resulted in increased levels of eIF2α phosphorylation. Tubulin served as a loading control. The values below the blot indicate the fold change in p-eIF2α levels relative to
control. (G) Expression levels of BiP and CHOP following treatmentwith CsA in the presence (+) or absence (−) of salubrinal. Treatmentwith Thapsigargin (TG, 1 μM) served as a positive
control for ER stress. (H) Relative level of BiP expression was quantiﬁed by NIH ImageJ software. The relative units obtained were normalized to tubulin to calculate the fold change in
expression in comparison to control. Three separate blots were quantiﬁed to calculate the relative change in BiP levels.
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apoptotic cell death [45]. In our study we found that knockdown of
cyclophilin B itself induces ER stress leading to increased expression
of BiP and IRE1α followed by massive cytoplasmic vacuolation. The
eIF2α levels remained the same but we found activation of JNK follow-
ing cyclophilin B knockdown. Altogether, these results indicate a link
between cyclophilin B inhibition and constitutive ER stress leading
eventually to cell death.
4.2. Cyclosporine A and non-apoptotic cell death response
It is evident fromour study that CsA treatment affects the cell survival
by growth inhibition and cell death. Apoptosis is reported to occur in a
variety of cell types treated with CsA [46–53], conversely CsA can also
inhibit apoptosis and change the fate of cells towards necrotic cell
death [20]. Overwhelming evidence indicates that persistent ER stress
causes apoptosis [54], however in the present study we describe CsA
triggered ER stress and vacuolation leading to non-apoptotic cell death.Two recent reports indicated that the cytoplasmic vacuoles appear in
pituitary [55] and glioma cell lines [56] following CsA treatment; addi-
tionally the vacuoles were autophagic in nature, and mild apoptosis
was also observed in the latter study. It is appropriate to compare the
results of this study with SiHa cells to that of glioma cells [56] on the
effects of CsA. The similarities include ER stress and vacuolation as
common effects of CsA. In SiHa cells vacuolation of ER is not associated
with markers of autophagosome and all attributes of apoptotic features
were lacking. Unlike the SiHa cells, the glioma cells showed the absence
of DNA fragmentation but activation of caspase and PARP cleavage were
observed. This difference could be attributed to the origin of cells and
to the higher concentration of CsA used to treat glioma cells (60 μM)
compared to SiHa cells (10–20 μM) used in the present study. The
concentration used in our study is closer to 1–5 μg/ml, equivalent to
0.833 μM–4.12 μM of CsA, detected in the blood of post-transplant
patients [20,37].
Cyclosporine A completely disrupted the ER structure as revealed by
the staining pattern of ER-resident proteins. ER-vacuolation in SiHa cells
Fig. 6. Cyclosporine Amediated ER stress and vacuolation is independent of calcineurin inhibition. (A) Calcineurin activity asmeasured in presence (+) or absence (−) of FK-506 (10 μM)
treatments. The bars representmean± s.e.m. from three independent experiments (⁎⁎P b 0.01 Student's Unpaired t-test). (B) Immunoblot analysis of FK-506 treated cells. BiP and IRE1α
levels didn't change following 10 μMFK-506 treatment in SiHa cells. (C) Cytoplasmic vacuolation is not seen in SiHa cells treatedwith 20 μMFK-506 for 48h,while cells treatedwith 20 μM
of CsA showedmassive vacuolation after 48 h. Images were taken using 40× objective. (D) Immunoblot analysis using cellular homogenate of HeLa cells following transfectionwith either
non-target (NT) shRNA or speciﬁc shRNA targeting the calcineurinα subunit (CaN shRNA). Note a 50% decline in calcineurin protein levels while the expression levels of ER stress related
genes BiP and PDI remain unchanged. (E) Phase contrast images of HeLa cells transfectedwith either non-target (NT) shRNA or shRNA targeting calcineurin (CaN shRNA) (PPP3CA). Note,
the cells appeared healthy and were devoid of any cytoplasmic vacuolations. (F) Immunoblot assay comparing the levels of ER stress marker, Bip following treatment of cells with
thapsigargin (TG, 2 μM 24 h, 48 h), tunicamycin (TM, 1 μg/ml, 24 h, 48 h) or CsA (10 μM, 24 h). (G) Phase contrast images of SiHa cells treated with ER stressors thapsigargin and
tunicamycin for 48 h showing cellular vacuolation (indicated by arrow).
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BiP, which is anti-apoptotic [57]. Another UPR dependent transcription
factor CHOP, promotes apoptosis [58]. Expression of Bip appeared early
and was stronger than CHOP in CsA-treated SiHa cells. Overexpression
of BiP at early stages was found to prevent CHOP-mediated apoptosis
[59]. Continued presence of ER stress with higher levels of BiP
may shift the fate of cells away from apoptosis, possibly towards non-
apoptotic cell death. Additionally, the inhibition of mitochondrial
permeability transition pore by cyclosporine A may interfere with the
release of cytochrome c thereby preventing apoptosis. An alternative
caspase-independent non-apoptotic death pathwaymay become active
under conditions of persisting ER stress when apoptosis gets inhibited.There are three distinct lesser-known forms of caspase-independent
cell death, all of which show distinct cytoplasmic vacuolation viz.,
methuosis, oncosis and paraptosis. Methuosis, a form of cell death
seen only in neuronal cell types, is due to micropinocytosis caused by
activated Ras [60]. Increased Ras activity in CsA-treated SiHa cells,
intriguingly, did not elicit the downstream Raf or ERK signalling.
In addition, lack of uptake of neutral red by the cells (following CsA
treatments) ruled out methuosis. Oncosis is another form of cell death
in which plasma membrane rupture occurred coupled with distinct
cytoplasmic vacuolation [61], but this is ruled out since plasma mem-
branewas intact in the vacuolated SiHa cells attached to the substratum
as indicated by lack of propidium iodide uptake.
Fig. 7. Effect of cyclosporine A on expression of cyclophilin B and knocking down of cyclophilin B results in ER stress mediated vacuolation. (A,B) Cyclophilin B (CypB) expression in SiHa
cells treatedwith (+) andwithout (−) CsA (10 μM). The immunoblotting experimentswere done in triplicate and one representative image is shown. The bar diagram represents the fold
decrease in levels of cyclophilinB following CsA treatment. The values representmean± s.e.m. from three independent experiments (⁎P b 0.05 Student'sUnpaired t-test). (C) Immunoblot
showing cyclophilin B expression following CsA treatment in the presence of either cycloheximide (ChX) or MG-132. SiHa cells were treatedwith either cycloheximide (5 μg/ml) orMG-
132 (5 μM) along with CsA (10 μM) for 24 h. (D) Quantiﬁcation of fold change in expression of cyclophilin B under various treatment conditions as represented in Fig. 7C. The signal in-
tensity of cyclophilin B expression was quantiﬁed by the NIH ImageJ software, the relative units obtained were normalized to tubulin and the fold change was calculated for each time
interval with respect to untreated control (Ut). The values represent mean ± s.e.m. from three independent experiments. (E) Knockdown of cyclophilin B following siRNA (CypB
siRNA) transfection in HeLa cells. Non target (NT siRNA)was used as negative control. Note lower levels of cyclophilin B, by siRNA, is accompanied by increased level of ER stress marker,
BiP and increased IRE1α and activation of JNK. Values below the blot indicates fold change in knockdown cells as compared to control. (F) Cyclophilin B (Cyp B) knockdown by siRNA
results in cytoplasmic vacuolation in HeLa cells. Non target siRNA served as control. (G) Quantiﬁcation of the number of vacuoles following cyclophilin B knockdown (CypB KD) is
shown in bar diagram. Non-target siRNA (NT) served as control. Bars represent mean ± s.d. from two independent experiments (⁎P b 0.05 Student's Unpaired t-test).
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massive cytoplasmic vacuolations arising from dilation of ER-lumen,
and retention of the plasma membrane integrity [34,60]. IGFIR-IC sig-
nalling, and SAPK/JNK and ERK-1/2 activation are implicated in this
type of cell death. AIP1/Alix, ALG2 interacting protein, has been reported
to inhibit IGFIR-IC-mediated paraptosis [35]. Accordingly, downregula-
tion of AIP1 levels is considered a marker of paraptosis [62]. Decreased
expression of AIP and activation of SAPK/JNK pathway, common with
paraptosis, was found in CsA-treated cells. Interestingly, CsA induced
JNK activation has been shown to be involved in tubular epithelial cell
phenotypic changes [63]. Bredesen and co-workers were the ﬁrst to
describe the phenomenon of paraptosis and showed that it is inhibited
by AIP1 [34,35]. However, we had some similarities and differences in
our results vis-à-vis that of Sperandio et al. [35]. As suggested by
them, JNK inhibitor was able to rescue the cellular survival in our
study too, intriguingly though AIP1 levels could not be rescued by JNK
inhibitor in CsA treated cells. Contrary to the report of Sperandio et al.
[35] that PI3K activation is not required for paraptosis; however we
found that AKT which is the downstream target of PI3K is activated by
CsA. To test the importance of early activation of PI3K in CsA induced
paraptosis, we treated the cells with its known inhibitor, wortmaninand found that indeed it was able to suppress the cellular vacuolation.
Our results indicate that modulation of AIP level is important for
paraptosis; however other key players may also be involved. Thus, the
events associated with induction of paraptosis, may be dictated by the
nature of the stress inducer and also the cellular context.
The paraptotic features of CsA treated cervical cancer cells could be
prevented by treatment with salubrinal which strongly increased the
eIF2α phosphorylation level. Salubrinal was noted to avert ER stress in
CsA treated cells [36,56]. The unfolded protein response, characterized
by increase in eIF2α phosphorylation, is a fail-safe mechanism
that helps the system to halt protein translation. CsA induced ER
stress coupled to unfolded protein response caused vacuolation and
decreased cell viability. Salubrinal on one hand prevented eIF2α de-
phosphorylation and also increased the levels of BiP and CHOP leading
to activation of UPR thereby, reiterating the UPR paradox of opposing
responses of either pro-survival or cell death, depending on the existing
conditions. In brief, salubrinal by halting the protein translation event
relieves the cellular stress and by increasing the levels of BiP and
CHOP helps in proper protein folding, thereby rescuing the cells from
undesired effects of accumulated unfolded proteins. Thus, an increase
in levels of ER-stress genes together with abrogation of c-junN terminal
Fig. 8. Cell death in CsA treated SiHa cells lacked the typical features of apoptosis. (A) Propidium iodide (PI) staining of SiHa cells treatedwith CsA (20 μM) at 48 h post treatment. Note the
absence of PI uptake by the vacuolated cells which are attached to the substratum, while the ﬂoating cells (arrow) stain with PI indicative of loss of membrane permeability. (B) Cells
stained with nuclear dye, DAPI, showed intact nuclei in CsA (20 μM) treated cells similar to control group, in contrast to 500 nM oleandrin (Olea) induced programmed cell death within
48 h as revealed by nuclear fragmentation and condensed chromatin (arrow). Note for this assay we removed the ﬂoating cells and stained only those cells which were adhered to the
substratum 48 h post treatment. (C, D) Cells were treated with (+) or without (−) CsA (10 μM) and analysed for cleavage of caspase 3 and PARP. The cleavage of these hallmark proteins
were conspicuously absent in CsA-treated cells unlike the positive control, oleandrin. By 120 h of CsA treatmentmajority of the dead cells started to ﬂoat and showed feeble PARP cleavage
suggestive of death different from apoptosis. Tubulin served as a loading control. (E) DNA fragmentation was detected by TUNEL staining using FACS. Untreated cells without TUNEL
staining served as a negative control. SiHa cells were either left untreated (control) or treated with CsA (20 μM) or camptothecin (10 μM) (inducer of apoptosis) for 48 h and stained
with TUNEL. The percentage of TUNEL negative cells are indicated in the P 1 gate and positive cells represented in the P 2 gate. Note that some amount of basal apoptosis (16%) was
seen in control cells. In CsA treated cells after subtracting the background intrinsic apoptosis (24.4%–16% = 8.4%) only minimal apoptosis was observed in CsA-treated cells. The 7.3%
TUNEL positive cells remaining in CsA + z-VAD treatment remain unaffected even after the addition of the pan-caspase inhibitor. In contrast reversal of apoptosis was seen on addition
of pan caspase inhibitor, Z-VAD-FMK in camptothecin treated cells.
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survival strategy preventing the CsA induced cellular vacuolation.
Collectively, the present study indicates that cyclosporine A by inhi-
bition of cyclophilin B can lead to constitutive ER stress leading to its di-
lation which ﬁnally culminates in non-apoptotic cell death resembling
paraptosis. We surmise a role of cyclophilin B inhibition and lowered
AIP1 levels to affect the viability of CsA treated cells. In conclusion, cy-
closporine A appears as a promising agent for understanding ER-related alternate cell death mechanisms which can be effectively
exploited for cell types which are otherwise resistant to apoptosis.
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Fig. 9. Effect of CsA on signalling pathways and induction of paraptosis. (A) Ras-RBD assay was performed to detect the Ras-GTP levels. Note the increase in both Ras-GTP and total Ras
levels following CsA (10 μM) treatment (+). A549 cells harbouring mutant Ras was used as positive control for Ras-GTP assay. (B) Immunoblotting analysis for activated Raf was carried
out using phosphorylated antibodies at different time intervals. p-Raf remained unaffectedwith CsA (10 μM) treatment. (C) An increase in phosphorylatedAKT (p-AKT) protein levelswas
observed in CsA treated cells at 24 h. Immunoblotting analysis for AIP1, amarker of paraptosis, showed a notable decline in its expression in CsA treated cells (⁎P b 0.05 Student's Unpaired
t-test). Tubulin was used as a loading control. (D, E) The expression levels of pAKT and AIP were quantiﬁed using “ImageJ” software and the relative units obtained were normalized to
tubulin and data plotted as fold change in expression compared to the control group. The bars represent mean± s.e.m. from three independent experiments. (F) MTT based cell viability
assay following treatment of SiHa cellswith either 20 μMof CsA alone or in presence of JNK inhibitor SP600125 (SP, 10 μM) for 72 h. (H) Immunoblot analysis showing levels of phosphorylated
JNK and AIP1 levels following treatment with cyclosporine A (CsA) or JNK inhibitor SP600125 (SP, 10 μM for 72 h) or both. (I, J) CsA induced vacuolation is prevented by the addition of
wortmannin (Wort) but not by MEK inhibitor U0126 (indicated by arrows). Cells were treated with wortmannin (10 μM) and U0126 (20 μM) alone or along with CsA (20 μM) for 48 h
and at least 300 cells were counted to calculate the percent vacuolation. Wortmannin treatment prevented vacuolation in SiHa cells upon CsA treatment. The bars represent mean ± s.e.m.
from three independent experiments (⁎P b 0.05 Student's Unpaired t-test).
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